Articoli con mandati relativi all'accesso pubblico - Sarah J TabriziUlteriori informazioni
Non disponibili pubblicamente: 26
Controlla
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
SJ Tabrizi, RI Scahill, A Durr, RAC Roos, BR Leavitt, R Jones, ...
The Lancet Neurology 10 (1), 31-42, 2011
Mandati: National Institute of Health and Medical Research, France
Controlla
The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation
M Papoutsi, I Labuschagne, SJ Tabrizi, JC Stout
Movement Disorders 29 (5), 673-683, 2014
Mandati: Australian Research Council, National Health and Medical Research Council …
Controlla
Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
M Politis, N Lahiri, F Niccolini, P Su, K Wu, P Giannetti, RI Scahill, ...
Neurobiology of disease 83, 115-121, 2015
Mandati: UK Medical Research Council, National Institute for Health Research, UK …
Controlla
Huntington disease
R Ghosh, SJ Tabrizi
Handbook of clinical neurology 147, 255-278, 2018
Mandati: UK Biotechnology and Biological Sciences Research Council, UK Medical …
Controlla
The structural involvement of the cingulate cortex in premanifest and early Huntington's disease
NZ Hobbs, AV Pedrick, MJ Say, C Frost, R Dar Santos, A Coleman, ...
Movement Disorders 26 (9), 1684-1690, 2011
Mandati: US National Institutes of Health, Canadian Institutes of Health Research
Controlla
A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers
A Sturrock, C Laule, K Wyper, RA Milner, J Decolongon, RD Santos, ...
Movement Disorders 30 (3), 393-401, 2015
Mandati: US National Institutes of Health, Canadian Institutes of Health Research …
Controlla
White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression
MJU Novak, KK Seunarine, CR Gibbard, NZ Hobbs, RI Scahill, CA Clark, ...
Cortex 52, 98-112, 2014
Mandati: Wellcome Trust
Controlla
Correction of inter-scanner and within-subject variance in structural MRI based automated diagnosing
D Kostro, A Abdulkadir, A Durr, R Roos, BR Leavitt, H Johnson, D Cash, ...
NeuroImage 98, 405-415, 2014
Mandati: German Research Foundation, UK Medical Research Council
Controlla
Disruption of immune cell function by mutant huntingtin in Huntington's disease pathogenesis
R Andre, L Carty, SJ Tabrizi
Current opinion in pharmacology 26, 33-38, 2016
Mandati: UK Medical Research Council, National Institute for Health Research, UK
Controlla
Peripheral inflammation in neurodegeneration
U Träger, SJ Tabrizi
Journal of Molecular Medicine 91, 673-681, 2013
Mandati: UK Biotechnology and Biological Sciences Research Council, UK Medical …
Controlla
Probabilistic classification learning with corrective feedback is selectively impaired in early Huntington’s disease—Evidence for the role of the striatum in learning with …
AK Holl, L Wilkinson, SJ Tabrizi, A Painold, M Jahanshahi
Neuropsychologia 50 (9), 2176-2186, 2012
Mandati: Parkinson's UK
Controlla
Safety and tolerability of selisistat for the treatment of Huntington’s disease: results from a randomized, double-blind, placebo-controlled phase II trial (S47. 004)
R Reilmann, F Squitieri, J Priller, C Saft, C Mariotti, S Suessmuth, ...
Neurology 82 (10_supplement), S47. 004, 2014
Mandati: German Research Foundation
Controlla
An MDS evidence‐based review on treatments for Huntington's disease
JJ Ferreira, FB Rodrigues, GS Duarte, TA Mestre, AC Bachoud‐Levi, ...
Movement Disorders 37 (1), 25-35, 2022
Mandati: Austrian Science Fund, Canadian Institutes of Health Research, German …
Controlla
Selective executive dysfunction but intact risky decision‐making in early Huntington's disease
AK Holl, L Wilkinson, SJ Tabrizi, A Painold, M Jahanshahi
Movement Disorders 28 (8), 1104-1109, 2013
Mandati: Parkinson's UK
Controlla
Structural imaging in premanifest and manifest Huntington disease
RI Scahill, R Andre, SJ Tabrizi, EH Aylward
Handbook of clinical neurology 144, 247-261, 2017
Mandati: UK Medical Research Council, Wellcome Trust
Controlla
Biomarker development for Huntington's disease
R Andre, RI Scahill, S Haider, SJ Tabrizi
Drug discovery today 19 (7), 972-979, 2014
Mandati: UK Biotechnology and Biological Sciences Research Council, UK Medical …
Controlla
Reduction of confounding effects with voxel-wise Gaussian process regression in structural MRI
A Abdulkadir, O Ronneberger, SJ Tabrizi, S Klöppel
2014 international workshop on pattern recognition in neuroimaging, 1-4, 2014
Mandati: US National Institutes of Health, German Research Foundation
Controlla
Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
R Reilmann, KE Anderson, A Feigin, SJ Tabrizi, BR Leavitt, JC Stout, ...
The Lancet Neurology 23 (3), 243-255, 2024
Mandati: UK Medical Research Council, Parkinson's UK, Michael J Fox Foundation
Controlla
One decade ago, one decade ahead in huntington's disease
EJ Wild, SJ Tabrizi
Movement Disorders 34 (10), 1434-1439, 2019
Mandati: UK Medical Research Council, National Institute for Health Research, UK …
Controlla
Huntington disease (Primer)
GP Bates, R Dorsey, JF Gusella, MR Hayden, C Kay, BR Leavitt, M Nance, ...
Nature Reviews: Disease Primers 1 (1), 2015
Mandati: Canadian Institutes of Health Research
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software